Literature DB >> 9922029

Intracellular interleukin-4 profiles during high-dose intravenous immunoglobulin treatment of therapy-resistant atopic dermatitis.

S Jolles1, J Hughes, M Rustin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 9922029     DOI： 10.1016/s0190-9622(99)70544-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Use of intravenous immunoglobulin in the treatment of childhood atopic dermatitis.

Authors:  Myung Hyun Sohn; Kyu-Earn Kim
Journal:  Allergy Asthma Immunol Res       Date:  2011-03-21       Impact factor: 5.764

2.  Intravenous immunoglobulin treatment in a child with resistant atopic dermatitis.

Authors:  Hyuck Hoon Kwon; Kyu Han Kim
Journal:  Ann Dermatol       Date:  2012-02-02       Impact factor: 1.444

3.  A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal.

Authors:  Ajit Rayamajhi; Sam Nightingale; Nisha Keshary Bhatta; Rupa Singh; Rachel Kneen; Elizabeth Ledger; Krishna Prasad Bista; Penny Lewthwaite; Chandeshwar Mahaseth; Lance Turtle; Jaimie Sue Robinson; Sareen Elizabeth Galbraith; Malgorzata Wnek; Barbara Wilmot Johnson; Brian Faragher; Michael John Griffiths; Tom Solomon
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

4.  Dupilumab Failure in Treating Dermatomyositis-Associated Pruritus.

Authors:  Margaret A O'Brien; Sylvia Hsu; Alina Shevchenko; Andrea Quartey
Journal:  Cureus       Date:  2022-08-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.